Real-time enrollment status for this recurrent plasma cell myeloma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT04508790 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Plasma Cell Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 29 participants |
| Active Locations | 8 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 13, 2026: Clinical trial NCT04508790 is currently recruiting participants. This clinical trial study for recurrent plasma cell myeloma is actively seeking new participants at 8 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04508790 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04508790 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.